✦ LIBER ✦

Safety of bevacizumab with or without anticoagulant treatment in neuro-oncological patients: A systematic review

✍ Scribed by Simonetti, G.; Trevisan, E.; Gaviani, P.; Lamperti, E.; Salmaggi, A.; Silvani, A.

Book ID: 123036279
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 53 KB
Volume: 333
Category: Article
ISSN: 0022-510X
DOI: 10.1016/j.jns.2013.07.2101

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety of bevacizumab in patients with m

Safety of bevacizumab in patients with malignant gliomas: a systematic review

✍ Simonetti, G.; Trevisan, E.; Silvani, A.; Gaviani, P.; Botturi, A.; Lamperti, E. 📂 Article 📅 2013 🏛 Springer Milan 🌐 English ⚖ 183 KB

Anticoagulation for the initial treatmen

Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer : A systematic review

✍ Elie A. Akl; Sandeep Rohilla; Maddalena Barba; Francesca Sperati; Irene Terrenat 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 312 KB 👁 1 views

## Abstract ## BACKGROUND. The authors compared the relative efficacy and safety of low‐ molecular‐weight heparin (LMWH) and unfractionated heparin (UFH) for the initial treatment of venous thromboembolism (VTE) between patients with and without cancer. ## METHODS. By using Cochrane methodology

Dual antiplatelet therapy with or withou

Dual antiplatelet therapy with or without oral anticoagulation in the postdischarge management of acute coronary syndrome patients with an indication for long term anticoagulation: a systematic review

✍ J. B. Washam; R. J. Dolor; W. S. Jones; S. A. Halim; V. Hasselblad; S. B. Mayer; 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 401 KB

Efficacy and safety of pharmacological i

Efficacy and safety of pharmacological interventions in second- or later-line treatment of patients with advanced soft tissue sarcoma: a systematic review

✍ Sharma, Sheetal; Takyar, Shweta; Manson, Stephanie C; Powell, Sarah; Penel, Nico 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 417 KB

Safety and Efficacy of 12-Week or Longer

Safety and Efficacy of 12-Week or Longer Indacaterol Treatment in Moderate-to-Severe COPD Patients: A Systematic Review

✍ Fa-Ming Jiang, Zong-An Liang, Qiao-Ling Zheng, Rong-Chun Wang, Jian Luo… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 649 KB

Safety of bevacizumab treatment in combi

Safety of bevacizumab treatment in combination with standard chemotherapy for metastatic colorectal cancer: a retrospective review of 65 Japanese patients

✍ Akihiro Tamiya; Kentaro Yamazaki; Narikazu Boku; Nozomu Machida; Takashi Kojima; 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 317 KB